Edition:
United Kingdom

DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

0.92USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$0.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
92,695
52-wk High
$2.55
52-wk Low
$0.85

Chart for

About

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)

Overall

Beta: 1.81
Market Cap(Mil.): $299.88
Shares Outstanding(Mil.): 147.00
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -0.25 -- --
ROI: -109.40 -0.29 14.22
ROE: -411.96 0.40 15.99

Earnings vs. Estimates